Immunoaffinity purification and functional characterization of human transcription factor IIH and RNA polymerase II from clonal cell lines that conditionally express epitope-tagged subunits of the multiprotein complexes.
Purification of multiprotein complexes such as transcription factor (TF) IIH and RNA polymerase II (pol II) has been a tedious task by conventional chromatography. To facilitate the purification, we have developed an effective scheme that allows human TFIIH and pol II to be isolated from HeLa-derived cell lines that conditionally express the FLAG-tagged p62 subunit of human TFIIH and the RPB9 subunit of human pol II, respectively. An approximate 2000-fold enrichment of FLAG-tagged TFIIH and a 1000-fold enhancement of total pol II are achieved by a one-step immunoaffinity purification. The purified complexes are functional in mediating basal and activated transcription, regardless of whether TATA-binding protein or TFIID is used as the TATA-binding factor. Interestingly, repression of basal transcription by the positive cofactor PC4 is alleviated by increasing amounts of TFIID, TFIIH, and pol II holoenzyme, suggesting that phosphorylation of PC4 by these proteins may cause a conformational change in the structure of PC4 that allows for preinitiation complex formation and initiation of transcription. Furthermore, pol II complexes with different phosphorylation states on the carboxyl-terminal domain of the largest subunit are selectively purified from the inducible pol II cell line, making it possible to dissect the role of carboxyl-terminal domain phosphorylation in the transcription process in a highly defined in vitro transcription system.
Kershnar
E
E
Department of Biochemistry, University of Illinois, Urbana, Illinois 61801, USA.
Wu
S Y
SY
Chiang
C M
CM
D002846:Chromatography, Affinity; D002999:Clone Cells; D004268:DNA-Binding Proteins / Q000378:metabolism; D000939:Epitopes / Q000032:analysis; D006367:HeLa Cells; D006801:Humans; D017874:Immediate-Early Proteins; D007700:Kinetics; D046911:Macromolecular Substances; D008565:Membrane Proteins; D046912:Multiprotein Complexes; D009842:Oligopeptides; D010455:Peptides / Q000032:analysis; D010766:Phosphorylation; D012319:RNA Polymerase II / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism*; D011994:Recombinant Proteins / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism; D012097:Repressor Proteins / Q000378:metabolism; D016385:TATA Box; D035181:TATA-Box Binding Protein; D015534:Trans-Activators / Q000378:metabolism; D035362:Transcription Factor TFIID; D051758:Transcription Factor TFIIH; D014157:Transcription Factors / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism*; D019473:Transcription Factors, TFII / Q000378:metabolism; D014158:Transcription, Genetic
D004268:DNA-Binding Proteins; D000939:Epitopes; C490043:IFRD2 protein, human; D017874:Immediate-Early Proteins; D046911:Macromolecular Substances; D008565:Membrane Proteins; D046912:Multiprotein Complexes; D009842:Oligopeptides; D010455:Peptides; D011994:Recombinant Proteins; D012097:Repressor Proteins; D035181:TATA-Box Binding Protein; D015534:Trans-Activators; D035362:Transcription Factor TFIID; D014157:Transcription Factors; D019473:Transcription Factors, TFII; D051758:Transcription Factor TFIIH; C085706:FLAG peptide; D012319:RNA Polymerase II